Fifth Third Wealth Advisors »

Lineage Cell Therapeutics In shares owned by Fifth Third Wealth Advisors

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Fifth Third Wealth Advisors from 13F filings

Historical chart of Fifth Third Wealth Advisors investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Fifth Third Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Fifth Third Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $30k 20k 1.48

More positions owned by Fifth Third Wealth Advisors

SPDR S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Select Divid Etf (DVY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Inc Core Msci Emkt (IEMG)

View all positions for Fifth Third Wealth Advisors

Top funds holding Lineage Cell Therapeutics In

BlackRock
Vanguard Group
Defender Capital
Geode Capital Management
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
Jpmorgan Chase & Co
Citadel Advisors
Nuveen Asset Management
Laurion Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Long Focus Capital Management
Connor, Clark & Lunn Investment Management

View all funds holding Lineage Cell Therapeutics In